Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Tischkowitz

Showing results (191-200 of 258) with videos related to

Pageof 26
Sort By:
The New England Journal of Medicine|August 8, 2014
Breast-cancer risk in families with mutations in PALB2Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, et al.
Human Mutation|May 22, 2019
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestryTara M Friebel, Irene L Andrulis, Judith Balmaña, et al.
Journal of Medical Genetics|May 17, 2015
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriersRachel S van der Post, Ingrid P Vogelaar, Fátima Carneiro, et al.
Nature Communications|May 13, 2025
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trialJean E Abraham, Lenka Oplustil O'Connor, Louise Grybowicz, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 28, 2025
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)Linda A J Hendricks, Katja C J Verbeek, Janneke H M Schuurs-Hoeijmakers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFrancisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2019
Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort ConsortiumHongyan Li, Mary Beth Terry, Antonis C Antoniou, et al.
Breast Cancer Research : BCR|June 20, 2023
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort ConsortiumKarin Kast, Esther M John, John L Hopper, et al.
Journal of the National Cancer Institute|February 29, 2020
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51DXin Yang, Honglin Song, Goska Leslie, et al.
Breast Cancer Research : BCR|February 28, 2020
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriersNasim Mavaddat, Antonis C Antoniou, Thea M Mooij, et al.
Pageof 26

Showing results (191-200 of 258) with videos related to

Sort By:
Pageof 26
The New England Journal of Medicine|August 8, 2014
Breast-cancer risk in families with mutations in PALB2Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, et al.
Human Mutation|May 22, 2019
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestryTara M Friebel, Irene L Andrulis, Judith Balmaña, et al.
Journal of Medical Genetics|May 17, 2015
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriersRachel S van der Post, Ingrid P Vogelaar, Fátima Carneiro, et al.
Nature Communications|May 13, 2025
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trialJean E Abraham, Lenka Oplustil O'Connor, Louise Grybowicz, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 28, 2025
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)Linda A J Hendricks, Katja C J Verbeek, Janneke H M Schuurs-Hoeijmakers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFrancisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2019
Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort ConsortiumHongyan Li, Mary Beth Terry, Antonis C Antoniou, et al.
Breast Cancer Research : BCR|June 20, 2023
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort ConsortiumKarin Kast, Esther M John, John L Hopper, et al.
Journal of the National Cancer Institute|February 29, 2020
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51DXin Yang, Honglin Song, Goska Leslie, et al.
Breast Cancer Research : BCR|February 28, 2020
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriersNasim Mavaddat, Antonis C Antoniou, Thea M Mooij, et al.
Pageof 26